| scholarly article | Q13442814 |
| P50 | author | Victoria Bae-Jump | Q87641363 |
| P2093 | author name string | Chunxiao Zhou | |
| Hui Guo | |||
| Hannah M Jones | |||
| Xiugui Sheng | |||
| Jessica E Stine | |||
| Adam K Willson | |||
| Lingqin Yuan | |||
| Dario R Roque | |||
| P2860 | cites work | Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species | Q24305112 |
| Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function | Q24306243 | ||
| Long-Term Clinical Outcome of Patients With Recurrent Epithelial Ovarian Carcinoma: Is it the Same for Each Histological Type? | Q37990743 | ||
| Ovarian cancer: risk factors, treatment and management | Q38143316 | ||
| Effects of glutamine on proliferation, migration, and differentiation of human dental pulp cells | Q38970931 | ||
| Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer | Q39024340 | ||
| Arginine, Leucine, and Glutamine Stimulate Proliferation of Porcine Trophectoderm Cells Through the MTOR-RPS6K-RPS6-EIF4EBP1 Signal Transduction Pathway1 | Q39181531 | ||
| Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance | Q39413719 | ||
| Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism | Q39708922 | ||
| Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells | Q40245593 | ||
| Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling | Q40443257 | ||
| Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells | Q40641888 | ||
| Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism | Q40738901 | ||
| Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells | Q42485472 | ||
| Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach. | Q42499348 | ||
| Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? | Q42858457 | ||
| Effects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathways | Q54630109 | ||
| The effect of the glutamine analog, AT-125, on the cell cycle of MCF-7 and BT-20 human breast carcinoma cells using DNA flow cytometry | Q72431072 | ||
| Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines | Q74624881 | ||
| Effect of glutamine analogue-acivicin on tumor induced angiogenesis in Ehrlich ascites carcinoma | Q81758538 | ||
| Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma | Q85931516 | ||
| Glutamine and cancer: cell biology, physiology, and clinical opportunities | Q27011818 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4 | Q28508613 | ||
| Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer | Q28609305 | ||
| Bidirectional transport of amino acids regulates mTOR and autophagy | Q29614476 | ||
| Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity | Q29616651 | ||
| Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924 | Q30410498 | ||
| Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells | Q30528073 | ||
| Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer | Q33604129 | ||
| Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer | Q34017200 | ||
| Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells | Q34161727 | ||
| Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy | Q34179999 | ||
| Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells | Q34258961 | ||
| Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis | Q34500273 | ||
| Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. | Q34645070 | ||
| Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells. | Q34782086 | ||
| Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle | Q34974267 | ||
| Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review | Q35099083 | ||
| Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer | Q35107599 | ||
| Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs | Q35567256 | ||
| WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. | Q35840116 | ||
| ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation | Q35899955 | ||
| Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells | Q36106835 | ||
| Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont | Q36345733 | ||
| ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. | Q36435476 | ||
| Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype | Q36484135 | ||
| Bridging epigenetics and metabolism: role of non-essential amino acids | Q36891887 | ||
| Bisphosphorylated PEA-15 Sensitizes Ovarian Cancer Cells to Paclitaxel by Impairing the Microtubule-Destabilizing Effect of SCLIP | Q36926900 | ||
| Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. | Q37311260 | ||
| Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. | Q37329509 | ||
| Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action. | Q37580909 | ||
| Glutamine: pleiotropic roles in tumor growth and stress resistance | Q37837590 | ||
| Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. | Q37873930 | ||
| Metabolic alterations in cancer cells and therapeutic implications | Q37908233 | ||
| The Warburg effect in 2012. | Q37962131 | ||
| P433 | issue | 4 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 577-591 | |
| P577 | publication date | 2015-06-04 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway. | |
| P478 | volume | 22 |
| Q57135523 | A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate |
| Q38792699 | Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling |
| Q132041462 | Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence |
| Q41779719 | Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer |
| Q37393426 | Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer |
| Q61797836 | Glutamine Addiction and Therapeutic Strategies in Lung Cancer |
| Q41116132 | Glutamine Deprivation Causes Hydrogen Peroxide-induced Interleukin-8 Expression via Jak1/Stat3 Activation in Gastric Epithelial AGS Cells |
| Q90705465 | Glutamine Metabolism Is Essential for Stemness of Bone Marrow Mesenchymal Stem Cells and Bone Homeostasis |
| Q37688120 | Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells |
| Q88960942 | Glutamine supplementation enhances development of in vitro-produced porcine embryos and increases leucine consumption from the medium |
| Q99711971 | In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach |
| Q36165662 | Low-mass-ion discriminant equation (LOME) for ovarian cancer screening |
| Q33626753 | MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer. |
| Q92875529 | Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance |
| Q45305650 | Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer. |
| Q89520914 | MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics |
| Q92545450 | PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming |
| Q48133992 | Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4). |
| Q132042932 | Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? |
| Q61798997 | The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1 |
| Q58694628 | The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ |
Search more.